Literature DB >> 28044308

Expression of Monomeric C-Reactive Protein in Infarcted Brain Tissue from Patients with Alzheimer's Disease.

Mark Slevin1, Donghui Liu, Glenn Ferris, Malik Al-Hsinawi, Raid Al-Baradie, Jerzy Krupinski.   

Abstract

OBJECTIVE: We have previously shown that monomeric-C-reactive protein is deposited in significant quantities within the brain parenchyma after stroke. Since we have recently identified a possible role of this protein in supporting neurodegeneration and aberrant vascular development we identified a small group of post-mortem brain samples from individuals who had Alzheimer's disease and evidence of tissue infarction/ micro-infarction on histological examination. MATERIAL AND
METHOD: We used immunohistochemistry staining to identify the monomeric-C-reactive protein expressed in the infarcted brain tissues.
RESULTS: We showed that monomeric-C-reactive protein deposition was highest in those regions affected by stroke or vascular disruption, and that within those same areas, there was more interaction and co-localization between major classical proteins of neurodegeneration (β-amyloid and tau).
CONCLUSION: We hypothesise that vascular disruption and concomitant release of monomeric-C-reactive protein within the brain tissue could exacerbate ongoing neurological damage via stimulation of neuro-inflammation and from direct consequences of its action on both neuronal and vascular cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28044308     DOI: 10.5146/tjpath.2016.01374

Source DB:  PubMed          Journal:  Turk Patoloji Derg        ISSN: 1018-5615


  4 in total

1.  Elevated C-Reactive Protein in Alzheimer's Disease Without Depression in Older Adults: Findings From the Health and Retirement Study.

Authors:  Ginny Natale; Sean A P Clouston; Dylan M Smith
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-04-01       Impact factor: 6.591

2.  Monomeric C-Reactive Protein Aggravates Secondary Degeneration after Intracerebral Haemorrhagic Stroke and May Function as a Sensor for Systemic Inflammation.

Authors:  Mark Slevin; Elisa García-Lara; Bogdan Capitanescu; Coral Sanfeliu; Yasmin Zeinolabediny; Raid AlBaradie; Peter Olah; Baoqiang Guo; Daniel Pirici; Mario Di Napoli; Aurel Popa-Wagner
Journal:  J Clin Med       Date:  2020-09-22       Impact factor: 4.964

3.  Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: A risk factor for Alzheimer's disease?

Authors:  Zhengrong Zhang; Hana Na; Qini Gan; Qiushan Tao; Yuriy Alekseyev; Junming Hu; Zili Yan; Jack B Yang; Hua Tian; Shenyu Zhu; Qiang Li; Ibraheem M Rajab; Jan Krizysztof Blusztajn; Benjamin Wolozin; Andrew Emili; Xiaoling Zhang; Thor Stein; Lawrence A Potempa; Wei Qiao Qiu
Journal:  Aging Cell       Date:  2021-10-23       Impact factor: 9.304

Review 4.  Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside.

Authors:  Mario Di Napoli; Mark Slevin; Aurel Popa-Wagner; Puneetpal Singh; Simona Lattanzi; Afshin A Divani
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.